Nebenwirkungen · Levemir
Levemir Penfill 100 units/ml solution for injection in cartridge. Levemir FlexPen 100 units/ml solution for injection in pre-filled pen. Levemir InnoLet 100 units/ml solution for injection in pre-filled pen. Levemir FlexTouch 100 units/ml solution for injection in pre-filled pen. · Abschnitt 4.8 · PDF-Seite 8
HOS-112652 · Präparat HOS-093711
Hypoglycaemia The most frequently reported adverse reaction is hypoglycaemia. It may occur if the insulin dose is too high in relation to the insulin requirement. Severe hypoglycaemia may lead to unconsciousness and/or convulsions and may result in temporary or permanent impairment of brain function or even death. The symptoms of hypoglycaemia usually occur suddenly. They may include cold sweats, cool pale skin, fatigue, nervousness or tremor, anxiousness, unusual tiredness or weakness, confusion, difficulty in concentrating, drowsiness, excessive hunger, vision changes, headache, nausea and palpitation.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2021-07-13T14:43:00Z · SHA-256 f2dce42e61ebc94b66c4ed9218db75538c2d50223fdd9ddd163a69c26e372423 · Passage 314ee52430ca2424dedba1a87ebe34377dbbc6cc91a4247fddf0a39ccf61ee90 · Zeichen 3667–4278 im Abschnitt